Key facts
- Lilly’s regular self-pay price for Foundayo is $149 a month for 0.8 mg, $199 for 2.5 mg, $299 for 5.5 mg and 9 mg, and $349 for 14.5 mg and 17.2 mg, for a 30-day supply.[1]
- Until 31 December 2026, 2.5 mg is temporarily $149 and 5.5 mg $199. The 14.5 mg and 17.2 mg doses are $299 if each refill is bought within 45 days of the last one.[1]
- With commercial insurance that covers Foundayo, the savings card brings the cost to as little as $25 for a 1, 2 or 3-month fill, capped at $100 off a month and $1,000 a year.[1]
- Eligible Medicare Part D patients pay $50 a month through the Medicare GLP-1 Bridge from 1 July 2026, after a prior authorisation.[2][3]
- Foundayo is a prescription medicine. It is not sold by DBR Labs, and this page is not medical or financial advice.
How Much Does Foundayo Cost?
Foundayo costs $149 to $349 a month self-pay depending on the dose, as little as $25 a month with commercial coverage and the savings card, and $50 a month for eligible Medicare Part D patients, according to Lilly’s pricing page on 8 November 2026.[1][2]
| Dose (once daily) | Regular self-pay price | Price to 31 Dec 2026 | Condition |
|---|---|---|---|
| 0.8 mg (starting dose) | $149 | $149 | None stated |
| 2.5 mg | $199 | $149 | Temporary reduction through 31 Dec 2026 |
| 5.5 mg | $299 | $199 | Temporary reduction through 31 Dec 2026 |
| 9 mg | $299 | $299 | None stated |
| 14.5 mg | $349 | $299 | Refill bought within 45 days of the previous fill |
| 17.2 mg (maximum dose) | $349 | $299 | Refill bought within 45 days of the previous fill[1] |
Regular prices stated by Lilly, checked 8 Nov 2026. Temporary and refill-timing offers are shown in the table above.
At launch on 1 April 2026, Lilly summarised the pricing as $25 a month with commercial insurance and the savings card, self-pay from $149 a month for the lowest dose, and $50 a month for eligible Medicare Part D patients from as soon as 1 July 2026.[3] Lilly sells Foundayo through LillyDirect with home delivery, and through US retail pharmacies and telehealth providers.[3]
How Much Is Foundayo Without Insurance?
Without insurance, Foundayo costs $149 a month at the 0.8 mg starting dose and up to $349 a month at 14.5 mg or 17.2 mg, or $299 for those two doses when each refill is bought within 45 days.[1]
- Self-pay prices run through Lilly’s Foundayo Self-Pay Savings Card, which needs a prescription for an approved use, US or Puerto Rico residence and an age of 18 or over.[1]
- The self-pay card may be used for up to 10 prescription fills per calendar year, and the card expires on 31 December 2026.[1]
- People with commercial insurance that does not cover Foundayo get the same prices: $149 (0.8 mg and 2.5 mg), $199 (5.5 mg) and $299 (9 mg, 14.5 mg and 17.2 mg).[1]
- Self-pay purchases operate outside insurance. You agree not to claim them back from any insurer or count them towards a deductible.[1]
- Lilly says Foundayo is HSA and FSA eligible, but eligibility may vary by plan.[1]
Foundayo Savings Card Terms
The Foundayo Savings Card lets eligible people with commercial coverage for Foundayo pay as little as $25 for a 1, 2 or 3-month fill, with savings capped at $100 a month and $1,000 a calendar year.[1]
| Term | Commercial coverage for Foundayo | Self-pay or no Foundayo coverage |
|---|---|---|
| What you pay | As little as $25 per 1, 2 or 3-month fill | $149 to $299 per 30-day fill, by dose |
| Maximum savings | $100 (1 month), $200 (2 months), $300 (3 months); $1,000 a year | $520 (0.8 mg, 2.5 mg), $470 (5.5 mg), $370 (9 mg to 17.2 mg) a month |
| Fills per year | Up to 10 | Up to 10 |
| Government plans | Excluded (Medicare, Medicaid, VA, TRICARE and others) | Cash only; no claims to any payer |
| Expiry | 31 Dec 2026 | 31 Dec 2026[1] |
- Both cards require a prescription for an approved use, US or Puerto Rico residence and an age of 18 or over.[1]
- The commercial card is not available to people whose plan uses an alternate funding programme that depends on the manufacturer card.[1]
- If the 45-day refill price for 14.5 mg or 17.2 mg is not applied at the till, Lilly offers a post-transaction reimbursement claim.[1]
- Lilly can change or end either card at any time, and states that the programme is not insurance.[1]
Foundayo with Insurance and Medicare
With commercial insurance that covers Foundayo, the cost can be as little as $25 a month with the savings card; on an eligible Medicare Part D plan it is no more than $50 a month through the Medicare GLP-1 Bridge from 1 July 2026.[1][2]
- Commercial insurance. Your cost depends on whether your plan covers Foundayo. Lilly’s page offers an insurance check tool and a separate prior authorisation page for prescribers.[1]
- Medicare GLP-1 Bridge. Eligible Part D patients prescribed Foundayo for weight management pay $50 for a 30-day supply. The bridge covers Foundayo only for obesity or weight management.[2]
- Medicare criteria. You need to be 18 or over, on an eligible Part D plan, and to have had a BMI of 35, or a BMI of 27 or higher with certain weight-related medical problems, before starting a GLP-1 medicine.[2]
- Prior authorisation. After the pharmacy runs the claim, your doctor completes a prior authorisation. Lilly says this is needed only for the first fill, including when the dose goes up later.[2]
- Medicaid, VA and TRICARE. People on these programmes cannot use the commercial savings card.[1] Lilly’s pages do not state a Foundayo price for them.
Foundayo Price vs Zepbound Vials and Wegovy
At the highest dose, Foundayo self-pay costs $299 to $349 a month, against $449 to $699 for Zepbound vials and $299 for the Wegovy pill at 25 mg, based on each maker’s own pricing page checked on 8 November 2026.[1][5][7]
| Medicine | Form | Lowest self-pay price | Highest-dose self-pay price | Page date |
|---|---|---|---|---|
| Foundayo (orforglipron) | Daily tablet | $149 (0.8 mg) | $349 (17.2 mg); $299 with refill within 45 days | CMAT-27550 08/2026[1] |
| Zepbound (tirzepatide) | Weekly single-dose vial | $299 (2.5 mg) | $699 (15 mg); $449 with refill within 45 days | CMAT-26402 09/2026[5] |
| Wegovy pill (semaglutide) | Daily tablet | $149 (1.5 mg) | $299 (25 mg) | US26SEMO01787 Oct 2026[7] |
| Wegovy pen (semaglutide) | Weekly pen | $199 (0.25 mg or 0.5 mg, first 2 fills for new patients to 31 Dec 2026) | $349 (2.4 mg); $399 (Wegovy HD 7.2 mg) | US26SEMO01787 Oct 2026[7] |
- Zepbound vial prices are $299 (2.5 mg), $399 (5 mg), $499 (7.5 mg) and $699 (10 mg, 12.5 mg and 15 mg) at the regular price, or $449 for 7.5 mg to 15 mg when each refill is bought within 45 days.[5]
- Wegovy pill self-pay prices are $149 (1.5 mg), $199 (4 mg) and $299 (9 mg and 25 mg).[7]
- With commercial coverage, Foundayo, the Wegovy pill and pen, and the Zepbound single-dose Pen (not the vial) can cost as little as $25 a month with the maker’s savings card. All are listed at no more than $50 a month for eligible patients under the Medicare GLP-1 Bridge.[1][6][7]
- Novo Nordisk says Wegovy prices do not rise based on when a prescription is refilled, unlike Lilly’s 45-day refill offers.[7]
A cheaper monthly price is not the same as better value, because the three medicines differ in trial results, side effects and how they are taken. For how orforglipron performed in trials, see what is orforglipron, and for other options see GLP-1 alternatives.
Why the Foundayo Price Varies by Dose
Lilly prices Foundayo by tablet strength, from $149 at 0.8 mg to $349 at 17.2 mg, and the label requires at least 30 days on each dose before stepping up, so the monthly cost usually rises over the first months.[1][4]
- Dose steps. The label starts everyone on 0.8 mg, then 2.5 mg and 5.5 mg after at least 30 days each. The dose may then rise to 9 mg, 14.5 mg or 17.2 mg, at least 30 days apart, based on response and tolerability.[4]
- First three months. At the temporary prices to 31 December 2026, the 0.8 mg, 2.5 mg and 5.5 mg steps cost $149, $149 and $199, or $497 in total. At regular prices they would be $149, $199 and $299, or $647.[1]
- Higher doses. The 9 mg dose is $299. The 14.5 mg and 17.2 mg doses are $349, or $299 if you refill within 45 days of the previous fill.[1]
- Missed doses. If 7 or more doses in a row are missed, the label says to restart escalation at a lower dose, which can change the price you pay.[4]
Is Foundayo Sold by DBR Labs?
No. Foundayo is a prescription medicine, from $149 a month self-pay through LillyDirect, US pharmacies and telehealth providers, and DBR Labs does not sell it or any orforglipron product.[1][3]
DBR Labs supplies research peptides for laboratory use only. Our eloralintide price guide covers eloralintide, an investigational research compound that is not approved anywhere; its research-vial prices are not comparable to the price of an approved prescription drug such as Foundayo.
Frequently Asked Questions
How much does Foundayo cost?
Foundayo costs $149 to $349 a month self-pay depending on the dose, as little as $25 a month with commercial insurance that covers it plus the Foundayo savings card, and $50 a month for eligible Medicare Part D patients through the Medicare GLP-1 Bridge. These are Lilly’s prices, checked on 8 November 2026.
How much is Foundayo without insurance?
Lilly’s regular self-pay prices are $149 for 0.8 mg, $199 for 2.5 mg, $299 for 5.5 mg and 9 mg, and $349 for 14.5 mg and 17.2 mg, per 30-day supply. Until 31 December 2026, 2.5 mg is $149 and 5.5 mg is $199, and 14.5 mg and 17.2 mg are $299 if each refill is bought within 45 days.
Is Foundayo cheaper than Zepbound?
On Lilly’s self-pay prices, yes. Foundayo runs from $149 to $349 a month, while Zepbound single-dose vials run from $299 to $699, or $449 for 7.5 mg to 15 mg with a refill within 45 days. The doses are not equivalent between the two medicines, and with commercial coverage the Foundayo card and the Zepbound single-dose Pen card can both bring the cost to as little as $25.
Does insurance cover Foundayo?
It depends on your plan. With commercial coverage for Foundayo you may pay as little as $25 a month with the savings card. Eligible Medicare Part D patients can get it for $50 a month through the Medicare GLP-1 Bridge for weight management, after a prior authorisation. Lilly says neither is a guarantee of coverage.
Is there a Foundayo savings card?
Yes. Lilly runs two: a commercial savings card that brings the cost to as little as $25 per fill, capped at $100 off a month and $1,000 a year, and a self-pay card with prices of $149 to $299 a month by dose. Both allow up to 10 fills a year, exclude government plans for the commercial card, and end on 31 December 2026.
Is Foundayo cheaper than Wegovy?
At the lowest doses they cost the same self-pay: $149 a month for Foundayo 0.8 mg and for the Wegovy pill at 1.5 mg. At the top doses, Foundayo 17.2 mg is $349, or $299 with a refill within 45 days, and the Wegovy pill at 25 mg is $299. The Wegovy pen is $349 a month after the introductory offer.
Sources
- Lilly, Foundayo coverage and savings page with savings card terms (page code CMAT-27550 08/2026, checked 8 Nov 2026)
- Lilly, Foundayo Medicare GLP-1 Bridge page (page code CMAT-32648 06/2026, checked 8 Nov 2026)
- Eli Lilly press release, 1 Apr 2026: FDA approves Foundayo (orforglipron)
- FDA. FOUNDAYO (orforglipron) tablets prescribing information, revised 07/2026 (NDA 220934, supplement 3)
- Lilly, Zepbound self-pay vial and KwikPen terms and conditions (page code CMAT-26402 09/2026, checked 8 Nov 2026)
- Lilly, Zepbound savings page (page code CMAT-26402 09/2026, checked 8 Nov 2026)
- Novo Nordisk, What to pay for Wegovy (page code US26SEMO01787 October 2026, checked 8 Nov 2026)
For research use only. Not for human or veterinary consumption. This guide summarises published research for information only. It is not medical advice and does not describe any use of products sold on this site.